(MedPage Today) — The FDA gave premarket approval to the first medical device for the treatment of women with symptomatic moderate-to-severe intrauterine adhesions, known as Asherman syndrome, maker Womed announced on Tuesday.
The resorbable…
Source link : https://www.medpagetoday.com/obgyn/generalobgyn/117501
Author :
Publish date : 2025-09-17 15:27:00
Copyright for syndicated content belongs to the linked Source.